Calendar  Volatility Report 11/10/2009  Volatility Report 11/11/2009  Volatility Report 11/12/2009  
Bristol-Myers Squibb Company (BMY) is at an implied volatility extreme high of 54.11% that is greater than 97.32% of past values prior to 11/11/2009 (Close Price 23.25). On prior close, 11/10/2009, the implied volatility was 31.12% and at the 68.79 percentile. Closing price was 23.34.

Today's News on Bristol-Myers Squibb Company

Earnings Preview: Pfizer to report 2Q earnings (AP)
Pfizer Inc., the world's biggest drugmaker by revenue, will discuss drug development, sales in developing markets and ongoing integration from its mega-acquisition of Wyeth when it reports second-quarter results before the stock market opens Tuesday.

Is Genzyme Worthy of a Sanofi Takeover? (at Minyanville)
Beyond all of Genzyme's baggage there still may be a solid biotech.

Sanofi CEO targeting everything but blockbusters (AP)
After 20 months running drugmaker Sanofi-Aventis SA, Chris Viehbacher wants to end the roller coaster of revenue peaks and valleys as blockbuster drugs climb to billions in sales and suddenly plummet when generic competition hits.

Merck Sags on Mixed Q2, Year View; Still Writing Down Schering (at Barron's Online)

A service of Trotter Trading Systems
Saturday, Jul 31, 2010